Rate My Professor Randall Holcombe

Prior to joining the University of Vermont in August 2021, Dr. Holcombe directed the University of Hawai‘i Cancer Center from 2016 to 2021, securing over $47 million in grant funding and leading its National Cancer Institute redesignation. He previously served as Deputy Director of the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai from 2010 to 2016, Associate Director of Clinical and Translational Research at the Chao Family Comprehensive Cancer Center at the University of California, Irvine from 1997 to 2010, and in faculty positions at Louisiana State University School of Medicine from 1989 to 1997. As principal investigator for over 150 cancer clinical trials, his research focuses on health services and cancer care delivery science, particularly quality improvement and rural populations; Wnt signaling mechanisms in colon cancer promoting invasion and metastasis; and natural products including resveratrol and genistein for cancer prevention and treatment, supported by investigator-initiated trials such as NCT00256334, NCT00578396, and NCT01985763. Dr. Holcombe has served on editorial boards for Anti-Cancer Drugs, Cancer Management and Research, and Journal of Oncology Practice, and held leadership roles in the Association of American Cancer Institutes and National Community Oncology Research Program. He has received the Best Doctors in America recognition multiple years.